Surgical outcome of metachronous hepatic metastases secondary to gastric cancer.
OBJECTIVE
The prognosis of hepatic metastasis from gastric carcinoma is dismal. A few patients are candidates for hepatic resection. The present study analyzed the oncologic outcomes of hepatic resection performed in metachronous hepatic metastasis from gastric cancer.


METHODS
Between January 1986 and November 2007, 14 patients underwent hepatectomy for metachronous hepatic metastasis secondary to gastric adenocarcinoma. Clinicopathological data were reviewed retrospectively.


RESULTS
The median interval between gastrectomy and hepatectomy was 12.9 months. The numbers of hepatic lesions were single in 9 patients, more than two in 5 patients. The overall survival rates following hepatectomy were 67.0% at 1 year, 38.3% at 3 year. The disease progression occurred in 10 patients in the remaining liver.


CONCLUSIONS
Surgical resection could be a treatment option for the hepatic metastasis from gastric cancer. The comparison of efficacy between surgical resection and the other treatment modalities will be required.
Choi
Sae Byeol
SB
Department of Surgery, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul, Korea 120-752.
Song
Jyewon
J
Kang
Chang Moo
CM
Hyung
Woo Jin
WJ
Kim
Kyung Sik
KS
Choi
Jin Sub
JS
Lee
Woo Jung
WJ
Noh
Sung Hoon
SH
Kim
Choong Bai
CB
D000230:Adenocarcinoma / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D000368:Aged; D015331:Cohort Studies; D005260:Female; D005743:Gastrectomy; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome